Bristol County Savings Bank’s Charitable Foundation awarded grants totaling $151,471 to 18 Rhode Island nonprofits during a ...

PROVIDENCE – Rhode Island Infrastructure Bank, the state’s central hub for financing infrastructure ...

What role do diversity, equity and inclusion play in your hiring and promotion decisions? Diversity, equity and inclusion are at the center of all of our decisions. We engage in redacting/scrubbing ...

MIDDLETOWN – A 4,600-square-foot home that was custom built on a 1.42-acre lot on a cul-de-sac recently sold for $2.64 million, according to public records. The 50 Elizabeth Lane home, constructed in ...

Health care may have received top billing in the revised $14.3 billion fiscal year 2026 budget lawmakers unveiled late Tuesday night, but the silent star is its Congressional counterpart. The federal ...

PROVIDENCE – Rhode Island health care advocates and leaders are celebrating the allocations for hospitals, medical practices and providers included in the proposed $14.3 billion fiscal year 2026 state ...

WARWICK – A worldwide travel and tour operator, a construction company, an insurance company and a nonprofit were recognized among 64 honorees in Providence Business News’ 2025 Best Places to Work ...

Critical RI business news and analysis updated daily. 1 year of print (26 issues). Unlimited access to all subscriber only content on our website, on any device. Free email alerts. Annual Book of ...

PROVIDENCE – A two-story brick colonial built in 1930 on the East Side of Providence recently sold for $1.7 million, according to Compass Inc., which represented both sides of the transaction. The 99 ...

Part of the Millers Brook Estates development, close to the town’s Monastery neighborhood, the 5,300-square-foot home contains a two-story foyer with hardwood floors and millwork features, according ...

PROVIDENCE – Federal, state and local leaders recently celebrated the Molar Express initiative’s expansion into the Blackstone Valley. The Molar Express is a nonprofit collaboration launched in 2007 ...

The cell therapy is known as CARVYKTI – which is a CAR-T, or chimeric antigen receptor-T cell, therapy – and has shown a 71% reduction in the risk of disease progression or death in clinical trials ...